CLDN1 and cholangiocarcinoma: The results show that either siMPS1 or MK2206 treatment significantly reduced phosphorylation of AKT (s473) and expression of slug and vimentin, but induced expression of claudin-1 when compared to untreated control (* p < 0.05) in both CCA cell lines.